CBR Agonist-2

• UNSPSC Description:

  CBR Agonist-2 is a CB1 agonist (CB1R; CB1 ligand) with an EC50 and a Ki of 960 nM and 970 nM, respectively. CBR Agonist-2 is a promising tool for investigating the involvement of hCB1R in disorders associated with the endocannabinoid system[1].

• Target Antigen:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/cbr-agonist-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CN(C2=CC=CC=C12)CCCCCF)NCC3=CC=CC=C3/N=N/C4=CC=CC=C4

• Molecular Weight:

  442.53

• References & Citations:

  [1]Diego A Rodríguez-Soacha, et al. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB 1 R) "Cis-On" Agonist. ACS Chem Neurosci.2022 Jul 26. doi: 10.1021/acschemneuro.2c00160.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported